nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—brain cancer	0.761	1	CbGaD
Pseudoephedrine—CYP2D6—Lomustine—brain cancer	0.025	0.569	CbGbCtD
Pseudoephedrine—CYP2D6—Hydroxyurea—brain cancer	0.019	0.431	CbGbCtD
Pseudoephedrine—IL2—blood vessel—brain cancer	0.00574	0.0957	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalic ventricle—brain cancer	0.00307	0.0511	CbGeAlD
Pseudoephedrine—SLC6A3—ganglion—brain cancer	0.00191	0.0318	CbGeAlD
Pseudoephedrine—NFATC1—head—brain cancer	0.0019	0.0316	CbGeAlD
Pseudoephedrine—IL2—endocrine gland—brain cancer	0.00176	0.0293	CbGeAlD
Pseudoephedrine—SLC6A4—ganglion—brain cancer	0.00175	0.0292	CbGeAlD
Pseudoephedrine—IL2—head—brain cancer	0.00174	0.0289	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—brain cancer	0.00173	0.0289	CbGeAlD
Pseudoephedrine—NFATC1—cerebellum—brain cancer	0.00169	0.0282	CbGeAlD
Pseudoephedrine—IL2—central nervous system—brain cancer	0.00158	0.0264	CbGeAlD
Pseudoephedrine—SLC6A2—ganglion—brain cancer	0.00154	0.0257	CbGeAlD
Pseudoephedrine—SLC6A3—hindbrain—brain cancer	0.00145	0.0241	CbGeAlD
Pseudoephedrine—MAOA—ganglion—brain cancer	0.00142	0.0236	CbGeAlD
Pseudoephedrine—NFATC1—brain—brain cancer	0.00137	0.0229	CbGeAlD
Pseudoephedrine—Cerebral haemorrhage—Carmustine—brain cancer	0.00136	0.0362	CcSEcCtD
Pseudoephedrine—SLC6A4—hindbrain—brain cancer	0.00133	0.0221	CbGeAlD
Pseudoephedrine—Cerebral haemorrhage—Temozolomide—brain cancer	0.00131	0.0349	CcSEcCtD
Pseudoephedrine—IL2—brain—brain cancer	0.00126	0.021	CbGeAlD
Pseudoephedrine—Paranoia—Carmustine—brain cancer	0.0011	0.0294	CcSEcCtD
Pseudoephedrine—ADRA1A—hindbrain—brain cancer	0.00109	0.0181	CbGeAlD
Pseudoephedrine—MAOA—hindbrain—brain cancer	0.00108	0.0179	CbGeAlD
Pseudoephedrine—SLC6A3—brainstem—brain cancer	0.00083	0.0138	CbGeAlD
Pseudoephedrine—SLC6A4—brainstem—brain cancer	0.00076	0.0127	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalon—brain cancer	0.000736	0.0123	CbGeAlD
Pseudoephedrine—Angina pectoris—Procarbazine—brain cancer	0.000735	0.0196	CcSEcCtD
Pseudoephedrine—ADRB1—telencephalon—brain cancer	0.000698	0.0116	CbGeAlD
Pseudoephedrine—SLC6A4—telencephalon—brain cancer	0.000675	0.0112	CbGeAlD
Pseudoephedrine—SLC6A2—brainstem—brain cancer	0.000669	0.0112	CbGeAlD
Pseudoephedrine—Pain—Carboplatin—brain cancer	0.000661	0.0176	CcSEcCtD
Pseudoephedrine—Sweating—Procarbazine—brain cancer	0.000645	0.0172	CcSEcCtD
Pseudoephedrine—Anorexia—Lomustine—brain cancer	0.000644	0.0171	CcSEcCtD
Pseudoephedrine—CYP2D6—hindbrain—brain cancer	0.000639	0.0107	CbGeAlD
Pseudoephedrine—ADRA1A—brainstem—brain cancer	0.000622	0.0104	CbGeAlD
Pseudoephedrine—MAOA—brainstem—brain cancer	0.000617	0.0103	CbGeAlD
Pseudoephedrine—Body temperature increased—Carboplatin—brain cancer	0.000611	0.0163	CcSEcCtD
Pseudoephedrine—Hallucination—Procarbazine—brain cancer	0.000601	0.016	CcSEcCtD
Pseudoephedrine—SLC6A2—telencephalon—brain cancer	0.000594	0.0099	CbGeAlD
Pseudoephedrine—Decreased appetite—Lomustine—brain cancer	0.000588	0.0156	CcSEcCtD
Pseudoephedrine—ADRA1A—telencephalon—brain cancer	0.000552	0.0092	CbGeAlD
Pseudoephedrine—MAOA—telencephalon—brain cancer	0.000547	0.00912	CbGeAlD
Pseudoephedrine—Dysuria—Hydroxyurea—brain cancer	0.000546	0.0145	CcSEcCtD
Pseudoephedrine—Arrhythmia—Procarbazine—brain cancer	0.00054	0.0144	CcSEcCtD
Pseudoephedrine—Body temperature increased—Lomustine—brain cancer	0.000534	0.0142	CcSEcCtD
Pseudoephedrine—SLC6A3—midbrain—brain cancer	0.000529	0.00881	CbGeAlD
Pseudoephedrine—Tension—Procarbazine—brain cancer	0.000516	0.0137	CcSEcCtD
Pseudoephedrine—SLC6A3—spinal cord—brain cancer	0.000516	0.0086	CbGeAlD
Pseudoephedrine—Nervousness—Procarbazine—brain cancer	0.000511	0.0136	CcSEcCtD
Pseudoephedrine—SLC6A2—gonad—brain cancer	0.000496	0.00826	CbGeAlD
Pseudoephedrine—Tremor—Procarbazine—brain cancer	0.000493	0.0131	CcSEcCtD
Pseudoephedrine—SLC6A4—midbrain—brain cancer	0.000484	0.00808	CbGeAlD
Pseudoephedrine—SLC6A4—spinal cord—brain cancer	0.000473	0.00788	CbGeAlD
Pseudoephedrine—SLC6A2—medulla oblongata—brain cancer	0.000467	0.00778	CbGeAlD
Pseudoephedrine—Hallucination—Hydroxyurea—brain cancer	0.000465	0.0124	CcSEcCtD
Pseudoephedrine—SLC6A3—head—brain cancer	0.000458	0.00764	CbGeAlD
Pseudoephedrine—Hypertension—Procarbazine—brain cancer	0.000454	0.0121	CcSEcCtD
Pseudoephedrine—Anxiety—Procarbazine—brain cancer	0.000446	0.0119	CcSEcCtD
Pseudoephedrine—MAOA—pituitary gland—brain cancer	0.000446	0.00743	CbGeAlD
Pseudoephedrine—ADRB1—endocrine gland—brain cancer	0.00044	0.00734	CbGeAlD
Pseudoephedrine—ADRB1—head—brain cancer	0.000435	0.00725	CbGeAlD
Pseudoephedrine—Confusional state—Procarbazine—brain cancer	0.000433	0.0115	CcSEcCtD
Pseudoephedrine—MAOA—medulla oblongata—brain cancer	0.00043	0.00717	CbGeAlD
Pseudoephedrine—Vomiting—Lomustine—brain cancer	0.00043	0.0114	CcSEcCtD
Pseudoephedrine—Dysuria—Temozolomide—brain cancer	0.000427	0.0114	CcSEcCtD
Pseudoephedrine—SLC6A4—endocrine gland—brain cancer	0.000426	0.00709	CbGeAlD
Pseudoephedrine—SLC6A4—head—brain cancer	0.00042	0.007	CbGeAlD
Pseudoephedrine—ADRA2A—telencephalon—brain cancer	0.00042	0.007	CbGeAlD
Pseudoephedrine—Tachycardia—Procarbazine—brain cancer	0.000419	0.0111	CcSEcCtD
Pseudoephedrine—SLC6A3—central nervous system—brain cancer	0.000418	0.00698	CbGeAlD
Pseudoephedrine—Hyperhidrosis—Procarbazine—brain cancer	0.000415	0.011	CcSEcCtD
Pseudoephedrine—Anorexia—Procarbazine—brain cancer	0.000409	0.0109	CcSEcCtD
Pseudoephedrine—SLC6A3—cerebellum—brain cancer	0.000409	0.00682	CbGeAlD
Pseudoephedrine—Phentermine—CYP2C9—brain cancer	0.000406	0.519	CrCbGaD
Pseudoephedrine—Nausea—Lomustine—brain cancer	0.000402	0.0107	CcSEcCtD
Pseudoephedrine—ADRB1—central nervous system—brain cancer	0.000397	0.00662	CbGeAlD
Pseudoephedrine—MAOA—midbrain—brain cancer	0.000393	0.00655	CbGeAlD
Pseudoephedrine—Insomnia—Procarbazine—brain cancer	0.000388	0.0103	CcSEcCtD
Pseudoephedrine—SLC6A4—central nervous system—brain cancer	0.000383	0.00639	CbGeAlD
Pseudoephedrine—MAOA—spinal cord—brain cancer	0.000383	0.00639	CbGeAlD
Pseudoephedrine—Selegiline—CYP2C9—brain cancer	0.000376	0.48	CrCbGaD
Pseudoephedrine—Hallucination—Carmustine—brain cancer	0.000376	0.01	CcSEcCtD
Pseudoephedrine—SLC6A2—endocrine gland—brain cancer	0.000375	0.00625	CbGeAlD
Pseudoephedrine—Decreased appetite—Procarbazine—brain cancer	0.000373	0.00993	CcSEcCtD
Pseudoephedrine—SLC6A2—head—brain cancer	0.00037	0.00617	CbGeAlD
Pseudoephedrine—Pain—Procarbazine—brain cancer	0.000367	0.00976	CcSEcCtD
Pseudoephedrine—CYP2D6—brainstem—brain cancer	0.000366	0.00611	CbGeAlD
Pseudoephedrine—Hallucination—Temozolomide—brain cancer	0.000363	0.00967	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Procarbazine—brain cancer	0.000354	0.00941	CcSEcCtD
Pseudoephedrine—ADRA2A—gonad—brain cancer	0.00035	0.00584	CbGeAlD
Pseudoephedrine—ADRA1A—endocrine gland—brain cancer	0.000348	0.00581	CbGeAlD
Pseudoephedrine—MAOA—endocrine gland—brain cancer	0.000345	0.00575	CbGeAlD
Pseudoephedrine—ADRA1A—head—brain cancer	0.000344	0.00573	CbGeAlD
Pseudoephedrine—ADRA2A—pituitary gland—brain cancer	0.000342	0.0057	CbGeAlD
Pseudoephedrine—MAOA—head—brain cancer	0.000341	0.00568	CbGeAlD
Pseudoephedrine—Body temperature increased—Procarbazine—brain cancer	0.000339	0.00903	CcSEcCtD
Pseudoephedrine—Arrhythmia—Carmustine—brain cancer	0.000338	0.00898	CcSEcCtD
Pseudoephedrine—SLC6A2—central nervous system—brain cancer	0.000338	0.00563	CbGeAlD
Pseudoephedrine—SLC6A3—brain—brain cancer	0.000332	0.00554	CbGeAlD
Pseudoephedrine—ADRA2A—medulla oblongata—brain cancer	0.00033	0.0055	CbGeAlD
Pseudoephedrine—CYP2D6—telencephalon—brain cancer	0.000325	0.00542	CbGeAlD
Pseudoephedrine—Anorexia—Hydroxyurea—brain cancer	0.000317	0.00842	CcSEcCtD
Pseudoephedrine—ADRB1—brain—brain cancer	0.000315	0.00525	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—brain cancer	0.000314	0.00523	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—brain cancer	0.000311	0.00519	CbGeAlD
Pseudoephedrine—Tremor—Carmustine—brain cancer	0.000308	0.0082	CcSEcCtD
Pseudoephedrine—Asthenia—Procarbazine—brain cancer	0.000308	0.00819	CcSEcCtD
Pseudoephedrine—ADRA1A—cerebellum—brain cancer	0.000307	0.00511	CbGeAlD
Pseudoephedrine—SLC6A4—brain—brain cancer	0.000304	0.00507	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—brain cancer	0.000304	0.00507	CbGeAlD
Pseudoephedrine—Agitation—Carmustine—brain cancer	0.000302	0.00804	CcSEcCtD
Pseudoephedrine—ADRA2A—midbrain—brain cancer	0.000302	0.00503	CbGeAlD
Pseudoephedrine—Tremor—Temozolomide—brain cancer	0.000298	0.00792	CcSEcCtD
Pseudoephedrine—Dyspnoea—Hydroxyurea—brain cancer	0.000296	0.00788	CcSEcCtD
Pseudoephedrine—ADRA2A—spinal cord—brain cancer	0.000294	0.0049	CbGeAlD
Pseudoephedrine—Dyspepsia—Hydroxyurea—brain cancer	0.000292	0.00778	CcSEcCtD
Pseudoephedrine—Agitation—Temozolomide—brain cancer	0.000292	0.00777	CcSEcCtD
Pseudoephedrine—Decreased appetite—Hydroxyurea—brain cancer	0.000289	0.00768	CcSEcCtD
Pseudoephedrine—Vertigo—Temozolomide—brain cancer	0.000286	0.0076	CcSEcCtD
Pseudoephedrine—Hypertension—Carmustine—brain cancer	0.000284	0.00756	CcSEcCtD
Pseudoephedrine—Pain—Hydroxyurea—brain cancer	0.000284	0.00756	CcSEcCtD
Pseudoephedrine—Dizziness—Procarbazine—brain cancer	0.000284	0.00755	CcSEcCtD
Pseudoephedrine—Palpitations—Temozolomide—brain cancer	0.000281	0.00748	CcSEcCtD
Pseudoephedrine—Chest pain—Carmustine—brain cancer	0.00028	0.00745	CcSEcCtD
Pseudoephedrine—Anxiety—Carmustine—brain cancer	0.000279	0.00743	CcSEcCtD
Pseudoephedrine—Hypertension—Temozolomide—brain cancer	0.000274	0.0073	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Hydroxyurea—brain cancer	0.000274	0.00728	CcSEcCtD
Pseudoephedrine—Vomiting—Procarbazine—brain cancer	0.000273	0.00726	CcSEcCtD
Pseudoephedrine—Confusional state—Carmustine—brain cancer	0.000271	0.0072	CcSEcCtD
Pseudoephedrine—Rash—Procarbazine—brain cancer	0.000271	0.0072	CcSEcCtD
Pseudoephedrine—Dermatitis—Procarbazine—brain cancer	0.00027	0.00719	CcSEcCtD
Pseudoephedrine—Anxiety—Temozolomide—brain cancer	0.00027	0.00718	CcSEcCtD
Pseudoephedrine—Headache—Procarbazine—brain cancer	0.000269	0.00715	CcSEcCtD
Pseudoephedrine—SLC6A2—brain—brain cancer	0.000268	0.00447	CbGeAlD
Pseudoephedrine—ADRA2A—endocrine gland—brain cancer	0.000265	0.00441	CbGeAlD
Pseudoephedrine—Body temperature increased—Hydroxyurea—brain cancer	0.000263	0.00699	CcSEcCtD
Pseudoephedrine—Tachycardia—Carmustine—brain cancer	0.000262	0.00697	CcSEcCtD
Pseudoephedrine—Confusional state—Temozolomide—brain cancer	0.000262	0.00696	CcSEcCtD
Pseudoephedrine—ADRA2A—head—brain cancer	0.000261	0.00436	CbGeAlD
Pseudoephedrine—Anorexia—Carmustine—brain cancer	0.000256	0.00681	CcSEcCtD
Pseudoephedrine—Nausea—Procarbazine—brain cancer	0.000255	0.00678	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Temozolomide—brain cancer	0.000251	0.00667	CcSEcCtD
Pseudoephedrine—ADRA1A—brain—brain cancer	0.000249	0.00415	CbGeAlD
Pseudoephedrine—Anorexia—Temozolomide—brain cancer	0.000247	0.00658	CcSEcCtD
Pseudoephedrine—MAOA—brain—brain cancer	0.000247	0.00412	CbGeAlD
Pseudoephedrine—Muscle spasms—Etoposide—brain cancer	0.000245	0.00651	CcSEcCtD
Pseudoephedrine—Insomnia—Carmustine—brain cancer	0.000243	0.00646	CcSEcCtD
Pseudoephedrine—Dyspnoea—Carmustine—brain cancer	0.000239	0.00637	CcSEcCtD
Pseudoephedrine—ADRA2A—central nervous system—brain cancer	0.000239	0.00398	CbGeAlD
Pseudoephedrine—Asthenia—Hydroxyurea—brain cancer	0.000238	0.00634	CcSEcCtD
Pseudoephedrine—Insomnia—Temozolomide—brain cancer	0.000235	0.00624	CcSEcCtD
Pseudoephedrine—Decreased appetite—Carmustine—brain cancer	0.000233	0.00621	CcSEcCtD
Pseudoephedrine—ADRA2A—cerebellum—brain cancer	0.000233	0.00389	CbGeAlD
Pseudoephedrine—Dyspnoea—Temozolomide—brain cancer	0.000231	0.00615	CcSEcCtD
Pseudoephedrine—Pain—Carmustine—brain cancer	0.00023	0.00611	CcSEcCtD
Pseudoephedrine—Vertigo—Etoposide—brain cancer	0.000229	0.00608	CcSEcCtD
Pseudoephedrine—Dyspepsia—Temozolomide—brain cancer	0.000228	0.00608	CcSEcCtD
Pseudoephedrine—Decreased appetite—Temozolomide—brain cancer	0.000226	0.006	CcSEcCtD
Pseudoephedrine—Pain—Temozolomide—brain cancer	0.000222	0.0059	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Carmustine—brain cancer	0.000221	0.00589	CcSEcCtD
Pseudoephedrine—Hypertension—Etoposide—brain cancer	0.00022	0.00584	CcSEcCtD
Pseudoephedrine—Dizziness—Hydroxyurea—brain cancer	0.00022	0.00584	CcSEcCtD
Pseudoephedrine—Chest pain—Etoposide—brain cancer	0.000217	0.00576	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Temozolomide—brain cancer	0.000214	0.00569	CcSEcCtD
Pseudoephedrine—Body temperature increased—Carmustine—brain cancer	0.000212	0.00565	CcSEcCtD
Pseudoephedrine—Vomiting—Hydroxyurea—brain cancer	0.000211	0.00562	CcSEcCtD
Pseudoephedrine—Rash—Hydroxyurea—brain cancer	0.000209	0.00557	CcSEcCtD
Pseudoephedrine—Confusional state—Etoposide—brain cancer	0.000209	0.00557	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydroxyurea—brain cancer	0.000209	0.00557	CcSEcCtD
Pseudoephedrine—Headache—Hydroxyurea—brain cancer	0.000208	0.00554	CcSEcCtD
Pseudoephedrine—CYP2D6—endocrine gland—brain cancer	0.000205	0.00342	CbGeAlD
Pseudoephedrine—Body temperature increased—Temozolomide—brain cancer	0.000205	0.00546	CcSEcCtD
Pseudoephedrine—Tachycardia—Etoposide—brain cancer	0.000203	0.00539	CcSEcCtD
Pseudoephedrine—CYP2D6—head—brain cancer	0.000203	0.00338	CbGeAlD
Pseudoephedrine—Hyperhidrosis—Etoposide—brain cancer	0.000201	0.00534	CcSEcCtD
Pseudoephedrine—Anorexia—Etoposide—brain cancer	0.000198	0.00527	CcSEcCtD
Pseudoephedrine—Nausea—Hydroxyurea—brain cancer	0.000197	0.00525	CcSEcCtD
Pseudoephedrine—Asthenia—Carmustine—brain cancer	0.000193	0.00513	CcSEcCtD
Pseudoephedrine—ADRA2A—brain—brain cancer	0.000189	0.00316	CbGeAlD
Pseudoephedrine—Asthenia—Temozolomide—brain cancer	0.000186	0.00495	CcSEcCtD
Pseudoephedrine—Dyspnoea—Etoposide—brain cancer	0.000185	0.00492	CcSEcCtD
Pseudoephedrine—CYP2D6—central nervous system—brain cancer	0.000185	0.00308	CbGeAlD
Pseudoephedrine—CYP2D6—cerebellum—brain cancer	0.000181	0.00301	CbGeAlD
Pseudoephedrine—Decreased appetite—Etoposide—brain cancer	0.00018	0.0048	CcSEcCtD
Pseudoephedrine—Dizziness—Carmustine—brain cancer	0.000178	0.00472	CcSEcCtD
Pseudoephedrine—Pain—Etoposide—brain cancer	0.000178	0.00472	CcSEcCtD
Pseudoephedrine—Dizziness—Temozolomide—brain cancer	0.000172	0.00457	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Etoposide—brain cancer	0.000171	0.00455	CcSEcCtD
Pseudoephedrine—Vomiting—Carmustine—brain cancer	0.000171	0.00454	CcSEcCtD
Pseudoephedrine—Rash—Carmustine—brain cancer	0.000169	0.0045	CcSEcCtD
Pseudoephedrine—Dermatitis—Carmustine—brain cancer	0.000169	0.0045	CcSEcCtD
Pseudoephedrine—Headache—Carmustine—brain cancer	0.000168	0.00448	CcSEcCtD
Pseudoephedrine—Vomiting—Temozolomide—brain cancer	0.000165	0.00439	CcSEcCtD
Pseudoephedrine—Body temperature increased—Etoposide—brain cancer	0.000164	0.00437	CcSEcCtD
Pseudoephedrine—Rash—Temozolomide—brain cancer	0.000164	0.00435	CcSEcCtD
Pseudoephedrine—Dermatitis—Temozolomide—brain cancer	0.000163	0.00435	CcSEcCtD
Pseudoephedrine—Headache—Temozolomide—brain cancer	0.000163	0.00432	CcSEcCtD
Pseudoephedrine—Nausea—Carmustine—brain cancer	0.000159	0.00424	CcSEcCtD
Pseudoephedrine—Nausea—Temozolomide—brain cancer	0.000154	0.0041	CcSEcCtD
Pseudoephedrine—Asthenia—Etoposide—brain cancer	0.000149	0.00396	CcSEcCtD
Pseudoephedrine—CYP2D6—brain—brain cancer	0.000147	0.00245	CbGeAlD
Pseudoephedrine—Dizziness—Etoposide—brain cancer	0.000137	0.00365	CcSEcCtD
Pseudoephedrine—Vomiting—Etoposide—brain cancer	0.000132	0.00351	CcSEcCtD
Pseudoephedrine—Rash—Etoposide—brain cancer	0.000131	0.00348	CcSEcCtD
Pseudoephedrine—Dermatitis—Etoposide—brain cancer	0.000131	0.00348	CcSEcCtD
Pseudoephedrine—Headache—Etoposide—brain cancer	0.00013	0.00346	CcSEcCtD
Pseudoephedrine—Nausea—Etoposide—brain cancer	0.000123	0.00328	CcSEcCtD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.76e-05	0.00039	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB2—brain cancer	3.74e-05	0.000388	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTCH2—brain cancer	3.7e-05	0.000385	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PDGFRA—brain cancer	3.68e-05	0.000382	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.67e-05	0.000382	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL2—brain cancer	3.67e-05	0.000381	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HES5—brain cancer	3.67e-05	0.000381	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—brain cancer	3.65e-05	0.000379	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HES5—brain cancer	3.59e-05	0.000373	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SPP1—brain cancer	3.57e-05	0.000371	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STRADA—brain cancer	3.56e-05	0.00037	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CTNNB1—brain cancer	3.54e-05	0.000368	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TRPC6—brain cancer	3.51e-05	0.000364	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STRADA—brain cancer	3.48e-05	0.000362	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—RELA—brain cancer	3.45e-05	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TRPC6—brain cancer	3.43e-05	0.000356	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—brain cancer	3.43e-05	0.000356	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB2—brain cancer	3.43e-05	0.000356	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—brain cancer	3.42e-05	0.000355	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CDK4—brain cancer	3.39e-05	0.000352	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—APC—brain cancer	3.37e-05	0.00035	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PIK3CG—brain cancer	3.37e-05	0.00035	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—IDH1—brain cancer	3.32e-05	0.000345	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—SHH—brain cancer	3.3e-05	0.000343	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CTNNB1—brain cancer	3.27e-05	0.00034	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—SHH—brain cancer	3.23e-05	0.000336	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IRS2—brain cancer	3.23e-05	0.000335	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TRPC6—brain cancer	3.18e-05	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PTCH1—brain cancer	3.13e-05	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—SMO—brain cancer	3.13e-05	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VAV1—brain cancer	3.13e-05	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TRPC6—brain cancer	3.12e-05	0.000324	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—STAT3—brain cancer	3.09e-05	0.000321	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.08e-05	0.00032	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTCH2—brain cancer	3.06e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—SMO—brain cancer	3.06e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PTCH1—brain cancer	3.06e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP2C9—brain cancer	3.04e-05	0.000315	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CTNNB1—brain cancer	3e-05	0.000311	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ABR—brain cancer	2.97e-05	0.000309	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HES5—brain cancer	2.97e-05	0.000308	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ABR—brain cancer	2.91e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STRADA—brain cancer	2.88e-05	0.000299	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GLI2—brain cancer	2.87e-05	0.000298	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—APC—brain cancer	2.85e-05	0.000296	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PIK3CG—brain cancer	2.85e-05	0.000296	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—STAT3—brain cancer	2.85e-05	0.000296	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTCH2—brain cancer	2.85e-05	0.000296	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TRPC6—brain cancer	2.84e-05	0.000295	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GLI2—brain cancer	2.81e-05	0.000292	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—brain cancer	2.81e-05	0.000292	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HES5—brain cancer	2.76e-05	0.000286	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—brain cancer	2.71e-05	0.000281	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GLI1—brain cancer	2.7e-05	0.00028	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STRADA—brain cancer	2.68e-05	0.000278	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—SHH—brain cancer	2.67e-05	0.000278	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MYC—brain cancer	2.65e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GLI1—brain cancer	2.64e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TRPC6—brain cancer	2.64e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—RELA—brain cancer	2.64e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—VAV1—brain cancer	2.63e-05	0.000273	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ENO2—brain cancer	2.63e-05	0.000273	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB2—brain cancer	2.62e-05	0.000272	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—STAT3—brain cancer	2.61e-05	0.000271	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—brain cancer	2.6e-05	0.00027	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—brain cancer	2.59e-05	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—BSG—brain cancer	2.58e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TRPC6—brain cancer	2.58e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—VAV1—brain cancer	2.57e-05	0.000267	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SUFU—brain cancer	2.56e-05	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTCH1—brain cancer	2.53e-05	0.000263	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—SMO—brain cancer	2.53e-05	0.000263	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SUFU—brain cancer	2.5e-05	0.00026	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—RELA—brain cancer	2.49e-05	0.000259	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—SHH—brain cancer	2.48e-05	0.000258	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ERBB2—brain cancer	2.48e-05	0.000257	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GFAP—brain cancer	2.47e-05	0.000256	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GFAP—brain cancer	2.41e-05	0.000251	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ABR—brain cancer	2.4e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TRPC6—brain cancer	2.39e-05	0.000249	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—VAV1—brain cancer	2.39e-05	0.000248	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—brain cancer	2.37e-05	0.000247	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—brain cancer	2.37e-05	0.000246	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTCH1—brain cancer	2.35e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—SMO—brain cancer	2.35e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HEY1—brain cancer	2.34e-05	0.000243	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—VAV1—brain cancer	2.33e-05	0.000242	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GLI2—brain cancer	2.32e-05	0.000241	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCND1—brain cancer	2.31e-05	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.3e-05	0.000239	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DLL1—brain cancer	2.29e-05	0.000238	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CTNNB1—brain cancer	2.29e-05	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HEY1—brain cancer	2.29e-05	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.28e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DLL1—brain cancer	2.24e-05	0.000233	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ABR—brain cancer	2.23e-05	0.000232	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RELA—brain cancer	2.23e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—IDH1—brain cancer	2.22e-05	0.00023	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB2—brain cancer	2.21e-05	0.00023	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GLI1—brain cancer	2.18e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CTNNB1—brain cancer	2.17e-05	0.000225	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GLI2—brain cancer	2.16e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	2.13e-05	0.000221	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SUFU—brain cancer	2.07e-05	0.000215	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GLI1—brain cancer	2.03e-05	0.000211	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—brain cancer	2.02e-05	0.000209	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—STAT3—brain cancer	2e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GFAP—brain cancer	2e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PIK3CG—brain cancer	1.98e-05	0.000206	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.98e-05	0.000205	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	1.98e-05	0.000205	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCND1—brain cancer	1.96e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SHH—brain cancer	1.95e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CTNNB1—brain cancer	1.94e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—VAV1—brain cancer	1.93e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SUFU—brain cancer	1.92e-05	0.0002	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SHH—brain cancer	1.91e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—brain cancer	1.91e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HEY1—brain cancer	1.89e-05	0.000197	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—STAT3—brain cancer	1.89e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TRPC6—brain cancer	1.88e-05	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DLL1—brain cancer	1.86e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MYC—brain cancer	1.86e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GFAP—brain cancer	1.86e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTCH1—brain cancer	1.85e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SMO—brain cancer	1.85e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TRPC6—brain cancer	1.84e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—brain cancer	1.82e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTCH1—brain cancer	1.81e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SMO—brain cancer	1.81e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—VAV1—brain cancer	1.79e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HEY1—brain cancer	1.76e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ENO2—brain cancer	1.75e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DLL1—brain cancer	1.73e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—brain cancer	1.72e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—brain cancer	1.71e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—STAT3—brain cancer	1.69e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—BSG—brain cancer	1.68e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	1.67e-05	0.000173	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PIK3CG—brain cancer	1.63e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SHH—brain cancer	1.58e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MYC—brain cancer	1.57e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—brain cancer	1.54e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—brain cancer	1.52e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TRPC6—brain cancer	1.52e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	1.52e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SMO—brain cancer	1.5e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTCH1—brain cancer	1.5e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PIK3CG—brain cancer	1.48e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOTCH2—brain cancer	1.48e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SHH—brain cancer	1.47e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOTCH2—brain cancer	1.45e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—IDH1—brain cancer	1.45e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TRPC6—brain cancer	1.41e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VAV1—brain cancer	1.41e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—brain cancer	1.4e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SMO—brain cancer	1.39e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTCH1—brain cancer	1.39e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VAV1—brain cancer	1.38e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.35e-05	0.00014	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—brain cancer	1.29e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.25e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.23e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HES1—brain cancer	1.21e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CG—brain cancer	1.2e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.2e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—brain cancer	1.19e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HES1—brain cancer	1.19e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—brain cancer	1.17e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PDGFRA—brain cancer	1.15e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—brain cancer	1.15e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ENO2—brain cancer	1.14e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.14e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.14e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PDGFRA—brain cancer	1.13e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SPP1—brain cancer	1.12e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.11e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SPP1—brain cancer	1.1e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—brain cancer	1.07e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.06e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—brain cancer	1.04e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS2—brain cancer	1.01e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS2—brain cancer	9.91e-06	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HES1—brain cancer	9.81e-06	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	9.5e-06	9.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	9.34e-06	9.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HES1—brain cancer	9.11e-06	9.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SPP1—brain cancer	9.07e-06	9.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—brain cancer	8.97e-06	9.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APC—brain cancer	8.95e-06	9.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CG—brain cancer	8.95e-06	9.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	8.83e-06	9.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APC—brain cancer	8.76e-06	9.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CG—brain cancer	8.76e-06	9.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	8.68e-06	9.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—brain cancer	8.63e-06	8.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SPP1—brain cancer	8.42e-06	8.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS2—brain cancer	8.2e-06	8.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—brain cancer	8.15e-06	8.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CG—brain cancer	8.05e-06	8.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—brain cancer	8.02e-06	8.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—brain cancer	7.98e-06	8.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS2—brain cancer	7.62e-06	7.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	7.24e-06	7.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APC—brain cancer	7.24e-06	7.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RELA—brain cancer	6.99e-06	7.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—brain cancer	6.95e-06	7.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RELA—brain cancer	6.84e-06	7.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—brain cancer	6.8e-06	7.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	6.73e-06	6.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APC—brain cancer	6.73e-06	6.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	6.6e-06	6.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—brain cancer	6.3e-06	6.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—brain cancer	6.16e-06	6.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—brain cancer	6.14e-06	6.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	6.13e-06	6.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CTNNB1—brain cancer	6.08e-06	6.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—brain cancer	6.01e-06	6.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CTNNB1—brain cancer	5.95e-06	6.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RELA—brain cancer	5.66e-06	5.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	5.62e-06	5.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—brain cancer	5.35e-06	5.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—brain cancer	5.3e-06	5.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RELA—brain cancer	5.26e-06	5.46e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CG—brain cancer	5.24e-06	5.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—brain cancer	5.24e-06	5.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	5.22e-06	5.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—brain cancer	5.18e-06	5.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—brain cancer	5.1e-06	5.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—brain cancer	4.97e-06	5.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—brain cancer	4.92e-06	5.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	4.92e-06	5.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—brain cancer	4.82e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—brain cancer	4.82e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—brain cancer	4.74e-06	4.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—brain cancer	4.71e-06	4.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—brain cancer	4.62e-06	4.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	4.57e-06	4.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	4.33e-06	4.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—brain cancer	4.29e-06	4.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—brain cancer	4.04e-06	4.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	4.02e-06	4.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—brain cancer	3.98e-06	4.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—brain cancer	3.98e-06	4.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—brain cancer	3.96e-06	4.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—brain cancer	3.9e-06	4.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—brain cancer	3.7e-06	3.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—brain cancer	3.62e-06	3.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—brain cancer	3.27e-06	3.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—brain cancer	3.04e-06	3.16e-05	CbGpPWpGaD
